✦ LIBER ✦

Re: Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab as First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

✍ Scribed by Wood, David P.

Book ID: 118484253
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 105 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.11.077

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on “Phase II trial of cisplat

Commentary on “Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04–75.” Hahn NM, Stadler WM, Zon RT, Waterhouse D, Picus J, Nattam S, Johnson CS, Perkins SM, Waddell MJ, Sweeney CJ; Hoosier Oncology Group, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN: J Clin Oncol 2011;29:1525–30

✍ H. Barton Grossman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Gemcitabine and carboplatin combination

Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group

✍ Helena Linardou; Gerassimos Aravantinos; Eleni Efstathiou; Charalambos Kalofonos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 116 KB

5019 Pegylated liposomal doxorubicin and

5019 Pegylated liposomal doxorubicin and Bevacizumab as first-line therapy for locallyrecurrent or metastatic breast cancer – a multicenter, single-arm phase II trial of the Swiss Group for Clinical Cancer Research (SAKK)

✍ C. Rochlitz; R. von Moos; M. Mannhart-Harms; R. Winterhalder; D. Rauch; A. Mülle 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

P-463 Preliminary results of a multicent

P-463 Preliminary results of a multicenter randomized phase II trial oftwo different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)

✍ Bernardini, I.; Rinaldi, M.; Crinò, L.; Nardi, M.; De Marinis, F.; Tonato, M.; S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Randomized multicenter Phase II trial of

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

✍ Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first‐line treatment in metastatic colorectal carcinoma (CRC). ## METHODS A total of 140 patients received capecitabine at a dose of 1